Cardiomyopathy Trial, Recruiting (NCT06889662)

Cardiomyopathy Trial, Recruiting NCT06889662 Sponsor: Scientific Institute San Raffaele Condition: Cardiomyopathy

Printed from Voxsanity (voxsanity.com.au) — NCT06889662 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cardiomyopathy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with myocarditis (inflammation of the heart muscle), confirmed by a heart tissue biopsy and/or a special type of heart MRI scan
You are 10 years old or older
You are willing to have your heart rhythm monitored remotely using an ECG device
You have given written consent to take part in the study

For healthy volunteers (people without myocarditis):

You have no known history of myocarditis
A blood or tissue sample from you has already been stored as part of a previous study called IMMUNORADAR

Who may not be able to join:

You have a significant blockage in the arteries that supply your heart (confirm with trial site)
If you are over 40 years old, you have not had a scan or test to check the arteries of your heart
You are not willing or able to give written consent to take part

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Paolo Della Bella, MD, Scientific Institute San Raffaele, Milan, Italy

Phone: 39+ 0226437340

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06889662

Sponsor: Scientific Institute San Raffaele

Phase: Not Applicable

Status: Recruiting

Condition: Cardiomyopathy

Trial contact: 39+ 0226437340

More information: https://clinicaltrials.gov/study/NCT06889662

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with myocarditis (inflammation of the heart muscle), confirmed by a heart tissue biopsy and/or a special type of heart MRI scan
You are 10 years old or older
You are willing to have your heart rhythm monitored remotely using an ECG device
You have given written consent to take part in the study

For healthy volunteers (people without myocarditis):

You have no known history of myocarditis
A blood or tissue sample from you has already been stored as part of a previous study called IMMUNORADAR

Who may not be able to join:

You have a significant blockage in the arteries that supply your heart (confirm with trial site)
If you are over 40 years old, you have not had a scan or test to check the arteries of your heart
You are not willing or able to give written consent to take part

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Scientific Institute San Raffaele

Registry

ClinicalTrials.gov

Start date

25 February 2025

Est. completion

1 September 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

To provide baseline characterization of VA in the study cohort.; To provide baseline characterization of VA in the study cohort.; To provide baseline characterization of VA in the study cohort.; To provide follow-up characterization of VA in study cohort.; To provide follow-up characterization of VA in study cohort.; To screen for CGVs in study groups; To screen for CGVs in study groups vs healthy controls; To investigate the pathophysiological basis of arrhythmic myocarditis in study group (exploratory endpoint)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov